• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Interpreting age-related aspects of antihypertensive treatment: statistical defects and their remedy.

作者信息

Murray G D, Lesaffre E, Robertson J I

机构信息

Department of Surgery, Western Infirmary, Glasgow, UK.

出版信息

J Hypertens Suppl. 1988 Nov;6(1):S121-6.

PMID:3063787
Abstract

Much of the literature concerning age-related effects in hypertension and its treatment suffers from serious deficiencies in statistical design and analysis. The problems include the measurement of response to treatment, the lack of a suitable control group, the way response is related to baseline blood pressure, the interpretation of post hoc analyses and the pooling of data from related but different studies. We discuss these problems and attempt to identify solutions which give a satisfactory balance between scientific validity and the practical issues of conducting clinical trials in hypertension.

摘要

相似文献

1
Interpreting age-related aspects of antihypertensive treatment: statistical defects and their remedy.
J Hypertens Suppl. 1988 Nov;6(1):S121-6.
2
Statistical pitfalls in the analysis of age-related effects in antihypertensive therapy.抗高血压治疗中年龄相关效应分析的统计学陷阱。
J Cardiovasc Pharmacol. 1988;12 Suppl 8:S167-73.
3
Comparative studies in hypertension: some fallacious claims of age-related drug efficacy.高血压的比较研究:一些关于年龄相关药物疗效的错误说法。
J Hypertens Suppl. 1990 Sep;8(4):S59-61.
4
The changing face of clinical trials.临床试验不断变化的面貌。
J Hypertens Suppl. 1988 Nov;6(1):S73-80.
5
[Clinical intervention trials: planning, performance and interpretation].[临床干预试验:规划、实施与解读]
Cardiologia. 1984 Jan-Feb;29(1-2):43-51.
6
Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.慢性抗高血压药物治疗下的血压反应:主动脉僵硬度在REASON(培哚普利在控制双盲试验中对动脉僵硬度的逆转作用)研究中的作用
J Am Coll Cardiol. 2009 Feb 3;53(5):445-51. doi: 10.1016/j.jacc.2008.09.046.
7
Interpreting clinical trials of antirheumatic drug therapy.抗风湿药物治疗的临床试验解读
Bull Rheum Dis. 1986;36(2):1-10.
8
An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. European Working Party on High Blood Pressure in the Elderly (EWPHE).
Arch Int Pharmacodyn Ther. 1985 Jun;275(2):300-34.
9
General statistical design considerations of randomized clinical trials.随机临床试验的一般统计设计考量
Prog Clin Biol Res. 1988;264:61-70.
10
Dropouts and missing data in psychiatric clinical trials.精神科临床试验中的脱落与数据缺失
Am J Psychiatry. 2009 Nov;166(11):1295; author reply 1295-6. doi: 10.1176/appi.ajp.2009.09070959.

引用本文的文献

1
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.酮色林。对其药效学和药代动力学特性以及在高血压和外周血管疾病中的治疗潜力的综述。
Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010.
2
Newer beta blockers and the treatment of hypertension.新型β受体阻滞剂与高血压治疗
Cardiovasc Drugs Ther. 1991 Jun;5(3):577-87. doi: 10.1007/BF03029727.